
Is MRK (Merck & Co., Inc.) Halal or Haram?
Merck & Co. successfully passes all AAOIFI Shariah screens, making it a fully compliant stock for Muslim investors. The company maintains a conservative debt profile with a Debt to Market Cap ratio of 18.4%, well below the 33% threshold. Additionally, its interest-bearing income remains minimal at just 1.56% of total revenue, comfortably passing the 5% limit.
Price Chart (5D)
MRK — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 112.33 | 114.54 | 111.88 | 112.16 | 12.0M | -0.15% |
| 2026-04-30 | 109.34 | 112.24 | 108.63 | 109.18 | 17.1M | -0.15% |
| 2026-04-29 | 108.55 | 111.23 | 107.90 | 110.95 | 9.8M | +2.21% |
| 2026-04-28 | 111.52 | 111.91 | 109.71 | 110.03 | 7.2M | -1.34% |
| 2026-04-27 | 111.22 | 112.75 | 110.14 | 110.23 | 9.1M | -0.89% |
| 2026-04-24 | 113.74 | 114.03 | 111.50 | 111.90 | 7.1M | -1.62% |
| 2026-04-23 | 113.37 | 115.02 | 113.10 | 114.62 | 6.8M | +1.10% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for MRK
Business Activity
Permissible
Merck passes the business activity screen as its core revenue comes from permissible healthcare innovations, including human pharmaceuticals like oncology drugs and vaccines, alongside animal health solutions.
Debt / Market Cap
18.44%
Interest Income
1.56%
Cash & Securities
5.32%
About Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a global healthcare leader operating across human pharmaceuticals and animal health. The company is renowned for its life-saving innovations in oncology, immunology, and virology, as well as its extensive portfolio of pediatric and adult vaccines.
For Muslim investors, Merck represents a fully Halal investment opportunity, having passed all four AAOIFI screening criteria. Because its core business of drug manufacturing is permissible and its financial ratios remain within acceptable limits, investors can confidently hold this stock in their halal portfolios.
From an Islamic finance perspective, Merck's balance sheet is highly compliant. The company's debt-to-market cap sits comfortably at 18.4%, and its cash and interest-bearing securities account for only 5.3% of its market capitalization, showing minimal reliance on interest-based leveraging.
While the stock is currently compliant, Muslim investors should continue to monitor its interest income, which currently stands at a safe 1.56% of revenue. Any significant shifts in cash management or corporate acquisitions could impact these financial ratios in future quarters.
MRK Key Financial Statistics
Revenue
$65.01B
Net Income
$18.25B
EPS (Diluted)
$7.28
Stock Price
110.94
Beta
0.28
52-Week Range
73.31-125.14
Total Debt
$50.53B
Total Equity
$52.61B
Current Ratio
1.54
MRK Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+1.3%
Prior year: $64.17B
Net Debt
$35.97B
Cash: $14.56B — Debt: $50.53B
R&D Spending
$15.60B
% of Revenue
24.0%
Frequently Asked Questions About MRK
Is MRK (Merck & Co., Inc.) stock halal to invest in?▾
What does Merck & Co., Inc. do?▾
What screening criteria were used for MRK?▾
Does MRK require income purification?▾
When was MRK last screened?▾
Disclaimer
This shariah compliance assessment for MRK (Merck & Co., Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.